financetom
Business
financetom
/
Business
/
Startup Street: Zepto raises $60 million and Zolve banks $40 million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Startup Street: Zepto raises $60 million and Zolve banks $40 million
Nov 1, 2021 11:14 AM

After operating in stealth mode for six months, grocery delivery app Zepto has raised an early-stage round of $60 million to expand its 10 minute grocery delivery nationwide.

The funding round now values the company at $225 million. 19-year-old founders, Aadit Palicha and Kaivalya Vohra, left behind computer science degrees at Stanford University to build Zepto.

Earlier known as KiranaKart, Zepto today enjoys backing from institutional investors like Glade Brook Capital, Nexus, Y Combinator, and individual investors including Lachy Groom, Neeraj Arora and more. To discuss the road ahead, Startup Street spoke to Aadit Palicha, founder and CEO, Zepto.

Also Read:

Why startup IPO can be a good bet

Neobanking startup, Zolve has bagged Rs 300 crore or $40 million in a Series A funding round at a valuation of Rs 1,575 crore. The round was led by partners of DST Global with participation from Tiger Global, Alkeon Capital as well as existing investors Accel and Lightspeed Venture Partners.

The Bengaluru headquartered startup, which is only 10 months old has now raised a total of $ 55 million. To discuss how it plans to spend its money and the road ahead for the company, Startup Street spoke to Raghunandan G, Founder and CEO of Zolve.

Chennai-based agro-tech and food start-up WayCool has seen its orders and revenues rise exponentially in the last 18 months. A decision to increase the number of its sourcing centres during the lockdown has led to the expansion of capacities, and this has spelt great news for the company's business.

Also Read: Zerodha unveils new Rs 100-crore ESOP plan: Report

CNBC-TV18's Jude Sannith spoke to WayCool's co-founder and CEO, Karthik Jayaraman to discuss how the pandemic led to changes in production methods.

Watch the video for more.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pimco Flexible Real Estate Income Fund Insider Bought Shares Worth $10,490,000, According to a Recent SEC Filing
Pimco Flexible Real Estate Income Fund Insider Bought Shares Worth $10,490,000, According to a Recent SEC Filing
Feb 7, 2025
04:07 PM EST, 02/07/2025 (MT Newswires) -- Daniel J Ivascyn, 10% Owner, on February 05, 2025, executed a purchase for 1,000,000 shares in Pimco Flexible Real Estate Income Fund (REFLX) for $10,490,000. Following the Form 4 filing with the SEC, Ivascyn has control over a total of 4,138,497 common shares of the company, with 4,058,889 shares held directly and 79,608...
Chewy Insider Sold Shares Worth $4,094,977, According to a Recent SEC Filing
Chewy Insider Sold Shares Worth $4,094,977, According to a Recent SEC Filing
Feb 7, 2025
04:07 PM EST, 02/07/2025 (MT Newswires) -- David Reeder, Chief Financial Officer, on February 05, 2025, sold 107,593 shares in Chewy (CHWY) for $4,094,977. Following the Form 4 filing with the SEC, Reeder has control over a total of 1,087,159 Class A common shares of the company, with 1,087,159 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1766502/000112760225003546/xslF345X05/form4.xml ...
Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing
Feb 7, 2025
04:09 PM EST, 02/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, General Counsel & Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml...
Update: Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members
Update: Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members
Feb 7, 2025
04:01 PM EST, 02/07/2025 (MT Newswires) -- (Updates with the lender in the first paragraph.) Entero Therapeutics ( ENTO ) got a $2 million revolving loan and appointed three new board members designated by the lender, 1396974 BC Ltd., as a condition for the funding. Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen...
Copyright 2023-2026 - www.financetom.com All Rights Reserved